The ABC Transporters MDR1 and MRP2: Multiple Functions in Disposition of Xenobiotics and Drug Resistance
- 1 January 2004
- journal article
- review article
- Published by Informa UK Limited in Drug Metabolism Reviews
- Vol. 36 (3-4), 669-701
- https://doi.org/10.1081/dmr-200033473
Abstract
ATP‐binding cassette (ABC) transporters comprise one of the largest membrane bound protein families. They are involved in transport of numerous compounds. These proteins transport substrates against a concentration gradient with ATP hydrolysis as a driving force across the membrane. Mammalian ABC proteins have important physiological, pharmacological and toxicological functions including the transport of lipids, bile salts, drugs, toxic and environmental agents. The efflux pumps serve both as natural defense mechanisms and influence the bioavailability and disposition of drugs. In general terms, the transporters remove xenobiotics from the cellular environment. For example, in cancer cells, over expression of these molecules may confer to multidrug resistance against cytostatic drugs. In addition, based on diverse structural characteristics and a broad substrate specifity, ABC transport proteins alter the intracellular concentration of a variety of therapeutically used compounds and toxicologically relevant agents. We review the function of the human multidrug resistance protein MDR1, (P‐glycoprotein, ABCB1) and the multidrug resistance protein MRP2 (ABCC2). We focus on four topics namely 1) structure and physiological functions of these transporters, 2) substrates e.g., drugs, xenotoxins, and environmental toxicants including their conjugates, 3) drug–drug interactions, and the role of chemosensitizers which may be able to reverse drug resistance, and 4) pharmacologically and toxicologically relevant genetic polymorphisms in transport proteins and their clinical implications.Keywords
This publication has 98 references indexed in Scilit:
- Interplay between MRP Inhibition and Metabolism of MRP Inhibitors: The Case of CurcuminChemical Research in Toxicology, 2003
- P-glycoprotein: from genomics to mechanismOncogene, 2003
- Strategies for reversing drug resistanceOncogene, 2003
- Altered conjugate formation and altered apoptosis of multidrug-resistant human leukemia cell line affects susceptibility to killing by activated natural killer (NK) cellsInternational Journal of Cancer, 2003
- Overexpression of cMOAT (MRP2/ABCC2) Is Associated with Decreased Formation of Platinum-DNA Adducts and Decreased G2-Arrest in Melanoma Cells Resistant to CisplatinJournal of Investigative Dermatology, 2003
- St John's Wort increases expression of P‐glycoprotein: Implications for drug interactionsBritish Journal of Clinical Pharmacology, 2002
- Efflux transport systems for drugs at the blood–brain barrier and blood–cerebrospinal fluid barrier (Part 2)Drug Discovery Today, 2001
- A Splice Mutation in the Human Canalicular Multispecific Organic Anion Transporter Gene Causes Dubin-Johnson SyndromeBiochemical and Biophysical Research Communications, 1998
- Dialkylquinonimines Validated as in Vivo Metabolites of Alachlor, Acetochlor, and Metolachlor Herbicides in RatsChemical Research in Toxicology, 1998
- Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cellsCancer Immunology, Immunotherapy, 1993